Creatine uptake regulates CD8 T cell antitumor immunity
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
T cells demand massive energy to combat cancer; however, the metabolic regulators controlling antitumor T cell immunity have just begun to be unveiled. When studying nutrient usage of tumor-infiltrating immune cells in mice, we detected a sharp increase of the expression of a CrT (Slc6a8) gene, which encodes a surface transporter controlling the uptake of creatine into a cell. Using CrT knockout mice, we showed that creatine uptake deficiency severely impaired antitumor T cell immunity. Supplementing creatine to WT mice significantly suppressed tumor growth in multiple mouse tumor models, and the combination of creatine supplementation with a PD-1/PD-L1 blockade treatment showed synergistic tumor suppression efficacy. We further demonstrated that creatine acts as a “molecular battery” conserving bioenergy to power T cell activities. Therefore, our results have identified creatine as an important metabolic regulator controlling antitumor T cell immunity, underscoring the potential of creatine supplementation to improve T cell–based cancer immunotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“reduce the progress of some forms of cancer [8,17,18,135,144,145,146,147];”
From Creatine in health and disease (2021) · cites this paper as [17]
In the citing paper
“Additionally, the creatine transport SLC6A8 gene expression encodes a surface transporter controlling the uptake of creatine into a cell, markedly increases in tumor-infiltrating immune cells [17].”
From Creatine in health and disease (2021) · cites this paper as [17]
In the citing paper
“Prior studies have shown that creatine content and energy availability are low in several types of malignant cells and T cells that mediate the immune responses against cancer [17,18,144,145,147].”
From Creatine in health and disease (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652 · cited 1×
“In particular, the PD-1hiTim3hiLAG-3hi tumor-infiltrating CD8 T cells, which are considered to be the most “exhausted,” expressed the highest levels of CrT, suggesting that these cells may also benefit the most from creatine supplementation treatment (Fig. S1 K; Nguyen and Ohashi, 2015; Wherry and Kurachi, 2015).”
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
A guide to immunometabolism for immunologists
O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 8×
“Expression of CrT is important for cells demanding high energy, such as muscle cells and brain cells; in humans, CrT deficiency has been associated with muscle diseases and neurological disorders (Wyss and Kaddurah-Daouk, 2000).”
InfluentialAdoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
Couzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051 · cited 2×
“T cells play a central role in mediating and orchestrating immune responses against cancer; therefore, they are attractive therapeutic targets for treating cancer (Couzin-Frankel, 2013; Page et al., 2014; Ribas, 2015; Rosenberg and Restifo, 2015; Baumeister et al., 2016; Lim and June, 2017).”
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W.-J., et al. (2014) · Nature · doi:10.1038/nature13988 · Cited by 1,974
The Principles of Engineering Immune Cells to Treat Cancer
Lim, W. A., & June, C. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.016 · Cited by 1,080 · cited 2×
“Mouse tumor models B16-OVA murine melanoma cells (obtained from the laboratory of Pin Wang, University of Southern California, Los Angeles, CA; Liu et al., 2014) and MC38 murine colon adenocarcinoma cells (obtained from the laboratory of Antoni Ribas, UCLA, Los Angeles, CA; Homet Moreno et al., 2016) were cultured in…”
Influential
Cited by
Items 101–132 of 132
Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway
Xu, Y., Yu, M., Zhang, Y., Jiang, Y., Haiyan, Z., He, S., Yu, G., Li, N., Liu, S., & Liu, B. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1774392 · Cited by 1
Zurdo-López, M. M., del Rio, M. S., Rudilla, M. C., Ibarra, A., & Doncel‐Pérez, E. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1815899 · Cited by 2
Cella, P. S., de Matos, R. L. N., Marinello, P. C., Guimarães, T. A. S., Nunes, J. H. C., Moura, F. A., Bracarense, A. P. F. R. L., Chimin, P., & Deminice, R. (2025) · Nutrition and Cancer · doi:10.1080/01635581.2025.2461257 · Cited by 1
Patent Highlights April–May 2021
Mucke, H. A. (2021) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2021-0011
Development and Validation A Prognostic Signature Based on Hypoxia-Related Gene for Thyroid CancerPreprint
Zhang, H., Li, S., & Li, W. (2021) · Research Square · doi:10.21203/rs.3.rs-823826/v1
Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma
Zhang, C.-Y., Liu, S., & Yang, M. J. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i9.1886
Avaliação do uso da suplementação de creatina e glutamina na recuperação do individuo
Campos, G. M., de Córdova, R. V., & Maynard, D. D. C. (2023) · Research Society and Development · doi:10.33448/rsd-v12i6.42268 · Cited by 2
Creatine - new hope in cancer treatment
Mądry, W., Mazurkiewicz, A., Marcicka, J., Kołodziej, M., Męczyńska, J., Saiuk, N., Kozicz, M. A., Seredyński, T., Wojciechowska, A., & Salasa, W. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.66.005
“[26] In another study, a beneficial effect of creatine supplementation on limiting the growth of the tumor was also observed.”
BackgroundMetabolic Reprogramming Driven by Ant2 -Targeting Augments T-Cell Function and Anti-Tumor ImmunityPreprint
Yosef, O., Cohen‐Daniel, L., Shamriz, O., Bar-On, Z., Saragovi, A., Abramovich, I., Agranovich, B., Lutz, V., Tam, J., Permyakova, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.21.590436
Wang, C., He, Y., Zhao, G., Ouyang, X., Wang, S., Chen, Y., Li, C., Jiang, Y., Xiong, T., He, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4817068/v1
Zhu, K., Lin, K., Shen, F., Zhang, H., Zhang, Y., Deng, B., Xue, Q., Guo, J., Wu, Q., Ai, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4939988/v1 · Cited by 1
Zhao, Y., & Zhang, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4942073/v1
Memudu, A. E., Alex, G. S., & Ihunwo, A. O. (2024) · Nutritional neurosciences · doi:10.1007/978-981-97-6341-2_9
Tang, Z., Li, J., Zhou, B., Zhang, B., Zhang, J., Cheng, S., Dong, W., Zhang, Y., Zhao, X., Zhang, Q., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145042
Lapeña-Luzón, T., Hernández-Bueno, A., Tomás‐Cobos, L., Moreno-Puente, P., García-Benlloch, S., Soriano-Romaní, L., & Marañón, J. A. (2025) · American Journal of Sports Science · doi:10.11648/j.ajss.20251302.14 · Cited by 1
Metabolic programming and immune suppression
Wang, Y., & Ma, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00054-0
Li, C., Pan, J., Luo, J., & Chen, X. (2021) · Figshare · doi:10.6084/m9.figshare.17097861
Li, C., Pan, J., Luo, J., & Chen, X. (2021) · Figshare · doi:10.6084/m9.figshare.17097867
Li, C., Pan, J., Luo, J., & Chen, X. (2021) · Figshare · doi:10.6084/m9.figshare.17097870
Li, C., Pan, J., Luo, J., & Chen, X. (2021) · Figshare · doi:10.6084/m9.figshare.17097858
Ng, C., Fung, T. S., Li, D., Kropp, K. N., Patterson, L. F. S., Markovitz, A., Weinberg, D. N., Jones, O., Kim, J.-Y., Zhang, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.27.714789
Solute carrier transporters in tumor metabolism and tumor immunity
Chen, M., Xu, J. F., Ma, H., Qin, J., Cheng, J., & Lv, J. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112084
CREATINE SUPPLEMENTATION IN INFLAMMATORY BOWEL DISEASE: LITERATURE REVIEW
Bułat, A., Sydor, M., Plizga, W., & Lepa, Z. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.4898
Shin, J., Neupane, R., Junior, G. L. L., Hussein, A., Ricci, T., & Kesselman, M. M. (2026) · Cureus · doi:10.7759/cureus.108384
“A total of five full-text articles were included in the final extraction results [7,12,23-25].”
InfluentialWang, J., Liao, C.-J., Lei, X., Peng, Z.-Z., Lin, Z.-L., Liu, J.-J., Liu, Q., Zhang, L., & Long, Z. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218637
Wang, K., Liu, C., He, J., Xu, M., Li, L., & Li, H. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118167 · Cited by 1
Wang, Y., Zhao, W., Jin, Y., Hu, C., Fang, X., Dong, S., & Zhang, B. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-01943-8
“Notably, T cells have a limited capac - ity for de novo creatine synthesis and depend on extracel - lular creatine uptake, suggesting that modulating creatine availability or pathway activity can influence T cell-mediated immunity (Di Biase et al. 2019 ; Li and Yang 2021 ).”
Xie, S., Chen, R., Sun, X., Ni, X., Wu, Y., Cai, L., Chen, Y., Lin, S., Rao, M., Chen, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74639-z
Yan, H., Qin, Q., Li, Y., Yang, L., Jiang, M., Xin, Y., Li, Y., Li, X., & Lu, J. (2026) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2026.102086
Spatiotemporal Multi‐Omic Mapping Reveals Liver‐Muscle Metabolic Crosstalk in Cancer Cachexia
Tian, Z., Wang, Q., Gao, W., Li, X., Fan, J., Wu, X., Liu, S., Ming, X., Yeerken, D., Shen, M., et al. (2026) · Advanced Science · doi:10.1002/advs.77489
Mitochondrial ATP promotes T cell differentiation through chromatin accessibility
Ng, C., Fung, T. S., Li, D., Kropp, K. N., Patterson, L. F. S., Markovitz, A., Weinberg, D. N., Jones, O., Kim, J.-Y., Zhang, G., et al. (2026) · Cell · doi:10.1016/j.cell.2026.08.023 · Cited by 1
Peter, B., Ongaro, M., Mager, L. F., Rochat, K., Gaillard, C., Breuillard, N., Poms, M., Serex, C., Godat, S., Braissant, O., et al. (2026) · Gut Science · doi:10.1136/gutsci-2026-000039
Metadata
- Authors
- Di Biase, S., Ma, X., Wang, X., Yu, J., Wang, Y.-C., Smith, D. J., Zhou, Y., Li, Z., Kim, Y. J., Clarke, N., To, A., & Yang, L.
- Affiliations
- Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 1
- University of California, Los Angeles (US)
- Corresponding author
- Yang, Lili
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2019-10-18
- Volume
- 216
- Issue
- 12
- Pages
- 2869-2882
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC6888972
- OpenAlex
- W2980348324
- Cited by
- 132
- References
- 40
- Citations by year
- 2026: 22 · 2025: 24 · 2024: 21 · 2023: 13 · 2022: 16 · 2021: 31 · 2020: 5
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- UCLA
- National Institutes of Health (DP2 CA196335)
- US Department of Health and Human Services (T32 CA009056)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- creatine uptake, SLC6A8, CD8+ T cells, antitumor immunity, T cell metabolism, creatine supplementation, PD-1/PD-L1 blockade, tumor-infiltrating immune cells, cancer immunotherapy
- MeSH terms
- Animals, Antigens, Neoplasm, Creatine, Energy Metabolism, Humans, Lymphocyte Activation, Models, Biological, Neoplasms, Gene Expression Regulation, Neoplastic, Mice, Knockout, CD8-Positive T-Lymphocytes, Dietary Supplements, Membrane Transport Proteins, Cell Line, Tumor, Mice, Immunomodulation, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.